DK2790710T3 - Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser - Google Patents

Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser Download PDF

Info

Publication number
DK2790710T3
DK2790710T3 DK12857932.3T DK12857932T DK2790710T3 DK 2790710 T3 DK2790710 T3 DK 2790710T3 DK 12857932 T DK12857932 T DK 12857932T DK 2790710 T3 DK2790710 T3 DK 2790710T3
Authority
DK
Denmark
Prior art keywords
treatment
bone disorders
malabsorption
metabolic bone
calcium
Prior art date
Application number
DK12857932.3T
Other languages
Danish (da)
English (en)
Inventor
Amir Sagi
Assaf Shechter
Galit Shaltiel-Gold
Oren Meiron
Michal Daniely
Original Assignee
Amorphical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorphical Ltd filed Critical Amorphical Ltd
Application granted granted Critical
Publication of DK2790710T3 publication Critical patent/DK2790710T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/612Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK12857932.3T 2011-12-13 2012-12-13 Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser DK2790710T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161569805P 2011-12-13 2011-12-13
US201261680721P 2012-08-08 2012-08-08
PCT/IL2012/050521 WO2013088440A1 (en) 2011-12-13 2012-12-13 Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders

Publications (1)

Publication Number Publication Date
DK2790710T3 true DK2790710T3 (da) 2020-11-30

Family

ID=48611949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12857932.3T DK2790710T3 (da) 2011-12-13 2012-12-13 Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser

Country Status (10)

Country Link
US (2) US10064890B2 (cg-RX-API-DMAC7.html)
EP (1) EP2790710B1 (cg-RX-API-DMAC7.html)
JP (3) JP2015500333A (cg-RX-API-DMAC7.html)
CN (2) CN109568338A (cg-RX-API-DMAC7.html)
AU (3) AU2012354056B2 (cg-RX-API-DMAC7.html)
CA (2) CA2859122C (cg-RX-API-DMAC7.html)
DK (1) DK2790710T3 (cg-RX-API-DMAC7.html)
ES (1) ES2831699T3 (cg-RX-API-DMAC7.html)
IL (2) IL233107B (cg-RX-API-DMAC7.html)
WO (1) WO2013088440A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507553A (ja) * 2013-02-11 2016-03-10 アモーフィカル リミテッド. 骨成長を促進する非晶質炭酸カルシウム
EP3174409A4 (en) 2014-07-31 2018-01-17 Amorphical Ltd. Encapsulated amorphous calcium carbonate compositions
US12121538B2 (en) 2015-06-04 2024-10-22 Amorphical Ltd. Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
HK1253702A1 (zh) * 2015-06-04 2019-06-28 艾玛菲克有限公司 用聚磷酸/聚磷酸酯/聚磷酸盐或双膦酸/双膦酸酯/双膦酸盐稳定的无定形碳酸钙
JP2017032550A (ja) * 2015-07-30 2017-02-09 大塚製薬株式会社 胃粘膜萎縮の有無を判定する方法
ES3052833T3 (en) 2016-01-18 2026-01-15 Amorphical Ltd Stabilized amorphous calcium carbonate as a supplement for cell culture media
US20230365935A1 (en) * 2016-01-18 2023-11-16 Amorphical Ltd. Stabilized amorphous calcium carbonate as a supplement for cell culture media
JP6873389B2 (ja) 2016-01-18 2021-05-19 アモーフィカル リミテッド. 神経学的、筋肉、および不妊の疾患または症状の治療のための安定化無定形炭酸カルシウム
JP6872680B2 (ja) * 2016-03-22 2021-05-19 国立大学法人 宮崎大学 カルシウム吸収促進剤
JP7152785B2 (ja) * 2016-10-25 2022-10-13 アモーフィカル リミテッド. 白血病治療のための非晶質炭酸カルシウム
CN110123836A (zh) * 2019-05-20 2019-08-16 昆明朗盛生物科技有限公司 钙锌维生素d泛酸片的应用
IL289237B2 (en) 2019-07-23 2026-03-01 Amorphical Ltd Amorphous calcium carbonate for improving athletic performance
WO2021181372A1 (en) * 2020-03-11 2021-09-16 Amorphical Ltd. Amorphous calcium carbonate for treatment of acidosis
US20230223125A1 (en) * 2020-05-04 2023-07-13 University Of Louisville Research Foundation, Inc. Artificial intelligence-based systems and methods for dosing of pharmacologic agents
CN121731510A (zh) * 2020-09-15 2026-03-27 昂科因凡特解决方案公司 尺寸可控的放射性标记粒子
JP7573310B2 (ja) * 2022-02-28 2024-10-25 一般社団法人 Unical ヒトによる経口摂取のためのカルシウム組成物
AU2023378960A1 (en) * 2022-11-08 2025-06-12 Amorphical Ltd. Methods for preparing amorphous calcium carbonate by fixation of carbon dioxide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3875867T2 (de) 1987-08-28 1993-04-01 Norwich Eaton Pharma Kalziumzusaetze.
GB2217988B (en) 1988-04-11 1992-04-01 Gould Leonard W Regimen for increasing bone density in humans
WO1997024069A1 (en) 1995-12-26 1997-07-10 Holomed Aps A method and system for generating an x-ray image
JPH10236957A (ja) 1997-02-24 1998-09-08 Bankaku Souhonpo:Kk 骨粗鬆症の改善剤
SE9702401D0 (sv) * 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
JP2003292453A (ja) * 2002-04-02 2003-10-15 Asahi Kasei Corp 骨疾患治療用医薬複合剤
US7267832B2 (en) * 2004-02-18 2007-09-11 Kraft Foods Holdings, Inc. Amorphous water-soluble calcium citrate salts and method of making and using same
CA2567972C (en) 2004-05-26 2015-07-28 Ben-Gurion University Of The Negev Research And Development Authority Orally-administrable compositions comprising stable amorphous calcium carbonate
US20070041506A1 (en) 2005-08-22 2007-02-22 Michelle Bottino Digital sensor holder
GB0522045D0 (en) 2005-10-28 2005-12-07 Novartis Ag Pharmaceutical compositions
IL178495A (en) * 2006-10-05 2014-12-31 Univ Ben Gurion Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
PL2211873T3 (pl) * 2007-10-22 2013-01-31 Amorphical Ltd Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów
WO2009087553A1 (en) 2008-01-02 2009-07-16 Aurobindo Pharma Limited Kits for administering bisphosphonates
CN101314031A (zh) 2008-07-14 2008-12-03 王冰 一种改善骨营养的制剂
EP2334292B1 (en) * 2008-10-17 2019-05-08 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient
CN102085356B (zh) 2010-12-28 2013-02-27 北京同仁堂健康药业股份有限公司 一种用于增加骨密度的组合物及其制备方法

Also Published As

Publication number Publication date
AU2012354056B2 (en) 2017-10-05
WO2013088440A1 (en) 2013-06-20
US20150056306A1 (en) 2015-02-26
ES2831699T3 (es) 2021-06-09
CA3056570A1 (en) 2013-06-20
CN104114179A (zh) 2014-10-22
AU2017279824A1 (en) 2018-01-25
EP2790710B1 (en) 2020-08-26
IL233107B (en) 2020-06-30
IL274755A (en) 2020-07-30
AU2012354056A1 (en) 2014-07-10
JP2015500333A (ja) 2015-01-05
JP2019214631A (ja) 2019-12-19
AU2020200704A1 (en) 2020-02-20
CA2859122A1 (en) 2013-06-20
WO2013088440A8 (en) 2013-08-01
IL274755B (en) 2021-04-29
CA2859122C (en) 2019-11-05
US10064890B2 (en) 2018-09-04
JP2018138591A (ja) 2018-09-06
CN109568338A (zh) 2019-04-05
EP2790710A1 (en) 2014-10-22
US20190022133A1 (en) 2019-01-24
US10688124B2 (en) 2020-06-23
EP2790710A4 (en) 2015-11-11
IL233107A0 (en) 2014-07-31
CA3056570C (en) 2022-04-19
AU2012354056A8 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
DK2790710T3 (da) Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser
DK2987507T3 (da) Fremgangsmåder til behandling af degenerative knogletilstande
DK3321276T3 (da) Fusionsproteiner til behandling af metaboliske lidelser
FR2976783B1 (fr) Materiel d'osteosynthese vertebrale
DK2371766T3 (da) Fremgangsmåde til at opnå præcipiteret calciumcarbonat
DK2632954T4 (da) Midler og fremgangsmåder til behandling af dlbcl
FR2982764B1 (fr) Implant rachidien intervertebral
BR112014010164A2 (pt) implante de tecido duro
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2555807T5 (da) Skabelon-øceller og små øcelleklynger til behandling af diabetes
DK2840065T3 (da) Fremgangsmåde til fremstilling af præcipiteret calciumcarbonat
DK2766483T3 (da) Fremgangsmåder og sammensætninger til screening for og behandling af udviklingsforstyrrelser
EP2575686A4 (en) ORTHOPEDIC IMPLANTS
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
IL228030B (en) Compounds for treating hyperuricemia and metabolic disorders associated with hyperuricemia
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2635282T3 (da) Sammensætninger til behandling af myelofibrose
DK2750551T3 (da) Ortopædisk stol til behandling og forebyggelse af rygmarvslidelser
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
BR112013031676A2 (pt) membro âncora para equipamento de osteossíntese vertebral
EP2713914A4 (en) BONE WRIST
DK2734212T3 (da) Sammensætninger omfattende diclofenac til behandling af postoperativ smerte
DK2436342T3 (da) Indretning til påføring af knoglesubstitutionsmateriale
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme
EP2758120A4 (en) ACCELERATED INSERT OF EAR IMPLANTS